Embassy Developments Limited
Analysts/Institutional Investor Meet/Con. Call Updates
Embassy Developments Limited has scheduled an earnings conference call to discuss its operational and financial performance for the quarter ended June 30, 2026.
BSE & NSE corporate filings with AI summaries
Embassy Developments Limited
Embassy Developments Limited has scheduled an earnings conference call to discuss its operational and financial performance for the quarter ended June 30, 2026.
Max Healthcare Institute Ltd
Max Healthcare Institute Ltd held its 25th Annual General Meeting on July 30, 2026, through video conference, with 160 members present. The meeting was conducted in compliance with the Companies Act, 2013, and relevant regulations. The Company Secretary informed members that the Notice of the meeting and the Integrated Annual Report for the financial year 2025-26 were sent to all members via email or through the Company's website.
Hero MotoCorp Ltd
Hero MotoCorp Ltd has announced its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The company's revenue from operations was ₹12,998.82 crore, with a total income of ₹13,439.71 crore. Expenses included cost of raw materials consumed, purchase of stock-in-trade, changes in inventories, employee benefits expense, finance costs, depreciation and amortisation expense, and other expenses.
Allcargo Global Ltd
Allcargo Global Ltd has informed BSE that the meeting of the Board of Directors is scheduled on August 14, 2026, to consider and approve the Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026.
7Seas Entertainment Ltd
7Seas Entertainment Ltd has scheduled a Board Meeting on 14/08/2026 to consider and approve the Un-Audited Financial Results for the Quarter Ended June 30, 2026.
IRM Energy Limited
IRM Energy Limited has announced its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, and has approved the extension of the timeline for utilizing the unutilized Initial Public Offering (IPO) proceeds up to March 31, 2028. The company has also recommended the appointment of new statutory auditors and fixed the record date for the dividend payment.
Bajaj Electricals Ltd-$
Bajaj Electricals Ltd has announced the voting results of its 87th Annual General Meeting (AGM), where all resolutions were passed with requisite majority. The company received the report of the Scrutinizer, confirming details of voting through e-voting system and e-voting facility provided during the AGM.
Bajaj Electricals Limited
Bajaj Electricals Limited has announced the voting results of its 87th Annual General Meeting (AGM), where all resolutions were passed with requisite majority. The company has also declared a dividend for the financial year ended March 31, 2026.
Hero MotoCorp Limited
Hero MotoCorp Limited has announced its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The results were approved by the Board of Directors and are enclosed with a limited review report. The company has also set up a new company under Section 8 of the Companies Act, 2013, to undertake Corporate Social Responsibility initiatives.
Hero MotoCorp Ltd
Hero MotoCorp Ltd has announced its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, with revenue from operations at ₹12,998.82 crore and a net income of ₹13,439.71 crore.
Sai Life Sciences Ltd
Sai Life Sciences Ltd has announced its unaudited financial results for the quarter ended 30 June 2026, with a profit before exceptional items and tax of ₹953.34 crore and a profit for the period of ₹713.39 crore.
Embassy Developments Ltd
Embassy Developments Ltd schedules an earnings conference call to discuss its operational and financial performance for Q1 FY2027.
Zen Technologies Limited
Zen Technologies Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on August 29, 2026, and has submitted the 33rd Annual Report for FY 2025-26.
Sai Life Sciences Ltd
Sai Life Sciences Ltd has announced its unaudited financial results for the quarter ended 30 June 2026, with a profit before tax of Rs. 953.34 crore and a profit for the period of Rs. 713.39 crore.
Parag Milk Foods Ltd
Parag Milk Foods Ltd has announced the outcome of its Board Meeting held on August 6, 2026, where it approved the expansion of its cheese manufacturing capacity by 60MT/day and appointed Mr. Rakesh Kothari as Chief Financial Officer (CFO) & Key Managerial Personnel (KMP). The company also disclosed its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026.
Patel Retail Ltd
Patel Retail Ltd has scheduled a Board meeting on August 12, 2026, to consider and approve the unaudited standalone financial results for the quarter ended June 30, 2026, and the trading window for dealing in the company's securities has been closed from July 1, 2026, until 48 hours after the declaration of the financial results.
Digjam Limited
Digjam Limited has announced its un-audited financial results for the quarter ended June 30, 2026, with current liabilities exceeding current assets by Rs. 2,107.75 lakhs. The company's sole manufacturing facility at Jamnagar was discontinued in March 2025, and related assets are classified as 'Non-current assets held for sale'. The financial results have been prepared on a going concern basis based on management's plans.
Tenneco Clean Air India Ltd
Tenneco Clean Air India Ltd has submitted its Annual Report for FY2025-26, including the Notice of 8th AGM, as per Regulation 34(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Shankara Building Products Ltd
Shankara Building Products Ltd, a subsidiary of Rane (Madras) Limited, has published unaudited financial results for the quarter ended June 30, 2026. The results show a total income from operations of Rs. 1,050.64 crores, a net profit for the period of Rs. 43.07 crores, and an earnings per share of Rs. 11.63.
Lupin Ltd
Lupin Ltd's Q1 FY2027 results show strong revenue growth with healthy EBITDA margins. The company launched several new products, including Azilsartan Medoxomil and Ranibizumab, and received approvals from US FDA and EMA. Lupin's India business grew 13.9% YoY, leveraging its chronic leadership position.